![]() Onconova Therapeutics Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer. | ![]() Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. | ![]() GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | ![]() Calithera Biosciences Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. | |
Founding Date | Founding Date 1998 | Founding Date 2006 | Founding Date 2003 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Newtown, US HQ Boston, US Newtown, US Pennington, US | Locations Houston, US HQ | Locations Rockville, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 1732% decrease | Employees 176% decrease | Employees 5025% increase | Employees 798% increase |
Valuation ($) | Valuation ($) 20.9 m | Valuation ($) 7.5 m | Valuation ($) 31.6 m | Valuation ($) 29.2 k |
Financial | ||||
Revenue (est.) | Revenue (est.) $2.8m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income $9.2m (FY, 2024) | Net income ($33.6m) (FY, 2025) | Net income ($153.9m) (FY, 2025) | Net income ($39.7m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 491k | Total funding raised $ 101.8m | Total funding raised $ 105m |

Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
View company
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
View company